You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 168 No. 7, April 14, 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Editor's Correspondence
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Nutrition/ Malnutrition
 •Cardiovascular System
 •Women's Health
 •Women's Health, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS & OPINIONS
Clinical Trials of Antioxidant Supplementation in the Prevention of Cardiovascular Events

Niki Katsiki, MD; Christos Manes, MD, PhD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The Women's Antioxidant Cardiovascular Study (WACS) was conducted to evaluate the effects of antioxidant vitamins on the risk of cardiovascular events.1 Regarding the limitations of this study, apart from the lack of complete follow-up and compliance reported by the authors, some other points should have been discussed. First, only women were included in the trial. No information about premenopausal or postmenopausal status of the study population was given. Moreover, dietary habits of the participants were not taken into account, despite the fact that antioxidant clinical studies should investigate the impact of a rich-in-antioxidant-nutrients diet in conjunction with the administration of vitamin supplements, as mentioned in the introduction.

Furthermore, the dose of vitamin E (600 IU every other day) may be responsible for the observed neutral results, since it is lower than the one (400 or 600 IU/d) used in the majority of the . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women: Results From the Women's Antioxidant Cardiovascular Study
Nancy R. Cook, Christine M. Albert, J. Michael Gaziano, Elaine Zaharris, Jean MacFadyen, Eleanor Danielson, Julie E. Buring, and JoAnn E. Manson
Arch Intern Med. 2007;167(15):1610-1618.
ABSTRACT | FULL TEXT  

Randomized Trials of Vitamin E in the Treatment and Prevention of Cardiovascular Disease
Rachel S. Eidelman, Danielle Hollar, Patricia R. Hebert, Gervasio A. Lamas, and Charles H. Hennekens
Arch Intern Med. 2004;164(14):1552-1556.
ABSTRACT | FULL TEXT  

RELATED LETTER

Clinical Trials of Antioxidant Supplementation in the Prevention of Cardiovascular Events—Reply
Nancy R. Cook, Christine M. Albert, JoAnn E. Manson, and for the WACS Investigator Group
Arch Intern Med. 2008;168(7):773-774.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.